Moschioni, M
~ 0  Ergebnisse:
Personensuche X
?
2

Assessment of Streptococcus pneumoniae pilus islet-1 preval..:

Turner, P. ; Melchiorre, S. ; Moschioni, M....
Clinical Microbiology and Infection.  18 (2012)  10 - p. 970-975 , 2012
 
?
3

Clonal Success of Piliated Penicillin Nonsusceptible Pneumo..:

Sjöström, K. ; Blomberg, C. ; Fernebro, J....
Proceedings of the National Academy of Sciences of the United States of America.  104 (2007)  31 - p. 12907-12912 , 2007
 
?
4

Clonal success of piliated penicillin nonsusceptible pneumo..:

Sjöström, K. ; Blomberg, C. ; Fernebro, J....
Proceedings of the National Academy of Sciences.  104 (2007)  31 - p. 12907-12912 , 2007
 
?
5

A pneumococcal pilus influences virulence and host inflamma..:

Barocchi, M. A. ; Ries, J. ; Zogaj, X....
Proceedings of the National Academy of Sciences.  103 (2006)  8 - p. 2857-2862 , 2006
 
?
6

A Pneumococcal Pilus Influences Virulence and Host Inflamma..:

Barocchi, M. A. ; Ries, J. ; Zogaj, X....
Proceedings of the National Academy of Sciences of the United States of America.  103 (2006)  8 - p. 2857-2862 , 2006
 
?
7

Cloning, expression, purification, and characterization of ..:

Romanello, V. ; Marcacci, M. ; Molin, F. Dal...
Protein Expression and Purification.  45 (2006)  1 - p. 142-149 , 2006
 
?
9

Evaluating newly approved drugs in combination regimens for..:

Patil, S, B ; Tamirat, M ; Khazhidinov, K...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-023-07701-6.  , 2023
 
?
10

Evaluating newly approved drugs in combination regimens for..:

Patil, S, B ; Tamirat, M ; Khazhidinov, K...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-023-07701-6.  , 2023
 
?
11

Evaluating newly approved drugs in combination regimens for..:

Patil, S. B ; Tamirat, M ; Khazhidinov, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688049/.  , 2023
 
?
12

Evaluating newly approved drugs for multidrug-resistant tub..:

Guglielmetti, L ; Ardizzoni, E ; ATGER, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-021-05491-3.  , 2021
 
?
13

Evaluating newly approved drugs for multidrug-resistant tub..:

Guglielmetti, L ; Ardizzoni, E ; Atger, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-021-05491-3.  , 2021
 
?
14

Evaluating newly approved drugs for multidrug-resistant tub..:

Guglielmetti, L ; Ardizzoni, E ; Atger, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-021-05491-3.  , 2021
 
?
15

Evaluating newly approved drugs for multidrug-resistant tub..:

Guglielmetti, L ; Ardizzoni, E ; Atger, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465691/.  , 2021
 
1-15